Plm. Vangiersbergen et R. Leppik, MODULATION OF AGONIST BINDING BY GUANINE-NUCLEOTIDES IN CHO CELLS EXPRESSING MUSCARINIC M1-M5 RECEPTORS, Naunyn-Schmiedeberg's archives of pharmacology, 352(2), 1995, pp. 166-172
In membranes prepared from CHO-m(2) cells, inhibition of [H-3]-N-methy
lscopolamine ([H-3]NMS) binding by several muscarinic agonists resulte
d in competition curves with Hill slopes significantly different from
unity. Addition of 5'-guanylylimidodiphosphate (Gpp(NH)p) led to an in
crease in the IC50 value of the agonists with significant steepening o
f the inhibition curves. The shift in potency induced by Gpp(NH)p diff
ered among the agonists with a rank order of oxotremorine-M = carbacho
l > oxotremorine > McN-A-343 = pilocarpine. In CHO-m4 membranes, Gpp(N
H)p was less efficacious than in CHO-m2 membranes whereas no effect of
the guanine nucleotide was found in membranes prepared from CHO-m1, -
m3, and -m5 cells. No major differences in the effect of Gpp(NH)p amon
g agonists were found in CHO-m4 cells. Atropine binding was not affect
ed by the guanine nucleotide. Together, these results indicate that co
upling of G-proteins to muscarinic receptors linked to inhibition of c
yclic adenosine monophosphate (cAMP) (m2 and m4) but not of those link
ed to phosphoinositol turnover (m1, m3 and m5) can be perturbed by Gpp
(NH)p. The differential effects observed with Gpp(NH)p between agonist
binding to m2 and m4 receptors appear to be receptor-specific and may
reflect differences in the G proteins activated by these receptors in
CHO cells.